NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
9 hedge funds and large institutions have $13.7M invested in NKGen Biotech, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
9
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.94M | |
| 2 | +$1.51M | |
| 3 | +$126K | |
| 4 |
Millennium Management
New York
|
+$50.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$43.2K |
Top Sellers
| 1 | -$6.01M | |
| 2 | -$3.91M | |
| 3 | -$3.61M | |
| 4 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$2.91M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.58M |